Septic Shock Following Flexible Transurethral Lithotripsy Showing Favourable Response after Multidisciplinary Treatment Mainly Composed of Recombinant Thrombomodulin : A Case Report by 加藤, 春雄 et al.
Titleトロンボモデュリン製剤を中心とした集学的治療が著効したf-TUL後の敗血症性ショックの1例
Author(s)加藤, 春雄; 柴田, 康博; 鈴木, 智美; 伊藤, 一人; 鈴木, 和浩








著効した f-TUL 後の敗血症性ショックの 1例
加藤 春雄，柴田 康博，鈴木 智美
伊藤 一人，鈴木 和浩
群馬大学大学院医学系研究科泌尿器科学
SEPTIC SHOCK FOLLOWING FLEXIBLE TRANSURETHRAL
LITHOTRIPSY SHOWING FAVOURABLE RESPONSE AFTER
MULTIDISCIPLINARY TREATMENT MAINLY COMPOSED OF
RECOMBINANT THROMBOMODULIN : A CASE REPORT
Haruo Kato, Yasuhiro Shibata, Tomomi Suzuki,
Kazuto Ito and Kazuhiro Suzuki
The Department of Urology, Gunma University Graduate School of Medicine
We herein present a case of a 65-year-old woman who developed severe septic shock following flexible
transurethral lithotripsy (f-TUL) showing favourable response after treatment with doripenem and
recombinant thrombomodulin (rTM). The patient underwent f-TUL for nephrolithiasis of the left kidney.
Preoperative urine culture indicated the presence of a mucoid strain of E. coli that was susceptible to
cefazolin ; therefore, the antibiotic cefazolin was administered as a preventive measure. The operation was
completed without any specific intraoperative complications. On the day following the operation, blood
pressure decreased and clouding of consciousness was observed. Hematological examination showed high
levels of procalcitonin, a decrease in platelet count, and high levels of fibrin degradation products (FDP),
indicative of severe septic shock and disseminated intravascular coagulation (DIC). The patient was
immediately shifted to the intensive care unit (ICU), and multidisciplinary treatment consisting of doripenem
(3 g/day) and rTM (380 U/kg) was administered. The medical treatment was successful ; the patient
recovered from DIC at an early stage and was able to leave the hospital within 10 days after the operation.
The risk of complications is expected to increase with the spread of f-TUL, and prompt action must be taken.
(Hinyokika Kiyo 58 : 499-502, 2012)

































cefcapene pivoxil hydrochloride hydrate を除いて感受性
は良好であったが，ムコイド型変異を示していた






















Fig. 1. Preoperative urine culture and sensitivity.
(Fig. 1）．
画像所見 : KUB では左サンゴ状結石を認めた．尿
管ステントが留置されていた (Fig. 2）．
手術所見 : 入院当日，全身麻酔下に Lt f-TUL を施
行した．予防抗菌薬として cefazolin を使用した．砕
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Fig. 3. The postoperative course table : Procalcitonin showed a rise from an early stage, and reacted more sensitively to
treatment compared with CRP.
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Fig. 2. KUB before f-TUL.
石にはオリンパス社製軟性腎盂尿管ビデオスコープ










し，翌朝に血圧 70 mmHg 台に低下を認め，血液検査
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にて WBC 12,700/μl，Plt 5.2万/μl，Cr 1.70 mg/dl，
PT 52％ (PT-INR 1.36），フィブリノーゲン 112 mg/
dl，FDP ＞420.0 μg/ml，D-ダイマー ＞240.0 μg/ml，
AT-III 58.0％，CRP 7.87 mg/dl，プロカルシトニン
133.16 ng/ml と異常値を示し，敗血症性ショック，




























対しても f-TUL 単独または ESWL との併用により積
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DIC の予後は多くは発症後 3∼ 5日以内の短期間の
治療内容により決定されるとされており，本症例では
DIC の診断後に適切な抗菌薬投与だけでなく，迅速





























リン製剤を主体とした迅速な DIC 治療が奏功した 1
例を経験し，若干の文献的考察を加え報告した．
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